Form 8-K - Current report:
SEC Accession No. 0001104659-04-022918
Filing Date
2004-08-06
Accepted
2004-08-06 13:09:44
Documents
3
Period of Report
2004-08-06
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a04-8950_18k.htm 8-K 15958
2 EX-99.1 a04-8950_1ex99d1.htm EX-99.1 99905
3 GRAPHIC g89501mmimage002.jpg GRAPHIC 14596
  Complete submission text file 0001104659-04-022918.txt   132344
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 04957115
SIC: 2836 Biological Products, (No Diagnostic Substances)